News Features
Acquisition Has Love Pharma’s Naltrexone on NIH Shortlist to Address Unmet Medical Need—Treatment for Long Covid
November 3, 2022 by in News Features
Acquisition Has Love Pharma’s Naltrexone on NIH Shortlist to Address Unmet Medical Need—Treatment for Long Covid
More
Share
News Features
Love Pharma’s Investment in US Biotech Offers Strategic Industry Advantages and Enhanced Shareholder Value
September 8, 2022 by in News Features
Love Pharma’s Investment in US Biotech Offers Strategic Industry Advantages and Enhanced Shareholder Value
More
Share
News Features
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins
January 27, 2020 by in News Features
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins
More
Share
News Features
PharmaCyte Biotech’s Release Testing Last Critical Event Before Submission of Investigational New Drug Application
November 12, 2019 by in News Features
PharmaCyte Biotech’s Release Testing Last Critical Event Before Submission of Investigational New Drug Application
More
Share
News Features
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology
October 28, 2019 by in News Features
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology
More
Share
News Features
PharmaCyte Biotech Nearing Major Milestone—An Open IND with the FDA
February 4, 2019 by in News Features
PharmaCyte Biotech Nearing Major Milestone—An Open IND with the FDA
More
Share